New Stem Cell Delivery Method Shows Promise for Treating End Stage Heart Failure

DURHAM, N.C., July 27, 2015 /PRNewswire-iReach/ — A new clinical trial to test how a high dose of stem cells delivered via a method called “retrograde coronary sinus infusion” affects end stage heart failure patients is showing promising results.

[Read the full article here]

Comments are closed.